Join ASPIRE for the first of two webinars in the use of ADD-ONS in assisted reproductive technology

Hot off the press!! Hear the results of the world’s largest randomised controlled trial of the use of ICSI in couples with non-male factor infertility. After nearly thirty years of use of microinjection (ICSI) and widespread adoption by IVF clinics the indications for ICSI remain uncertain. This is particularly with normal seminal analysis when ICSI might be considered an “Add-on”. This presentation by Dr. Ho Manh Tuong (Ho Chi Minh, Vietnam) summarises the current evidence for use of ICSI and shares the results of the latest randomised trial of ICSI vs IVF. This work and presentation are major step to establishing indications for ICSI and is a not-to-be-missed webinar.

Are you wanting to use sperm selection techniques to improve your patient success rates? Which ones are best? Which ones are easiest? Dr. George Liperis (Sydney, Australia) will take you through using available sperm selection techniques so you can decide which, if any, add-on you wish to use. Dr. Liperis will describe the basic science behind the available techniques and evidence supporting the use of each technique. This is an essential webinar for young embryologists and clinicians wishing to understand the science behind sperm selection and for the early adopters who provide services in assisted reproductive technology.

Watch the lecture recordings below and take advantage of your opportunity to ask questions about this exciting area of reproductive medicine. Questions will be addressed at the live forum session taking place on Saturday, 17 October 2020 at 10am GMT (+8). Leave your questions in the comment box below or send them to secretariat@aspire-reproduction.org.

Lecture 1: Breaking News: Is ICSI an Add-on?

Speaker: Dr. Ho Manh Tuong (Ho Chi Minh, Vietnam) [click to view speaker’s bio]

Data from European countries in the year 2015 showed that ICSI was used in an increasing rate of 71.2% of treatment cycles. The same trend has also been reported in the United States, South America and Asian countries. Interestingly, the largest indication for ICSI has been for couples with non-male factor infertility.

The rationale for using ICSI in couples with non-male factor infertility is based on an assumption that ICSI might avoid unexpected total fertilization failure and increase the number of embryos available. Over the last 20 years, ICSI has been widely implemented in clinical practice without a solid evidence from RCTs.

Most retrospective data showed that ICSI did not appear to significantly reduce total fertilization failure in couples with non-male factor infertility, even in women with a small number of oocytes due to poor ovarian response, yet there were data showed different results. Recent large RCT showed that, in general, ICSI for non-male factor infertility did not improve live birth rate compared to conventional IVF.

Yet, many specific indications of ICSI for non-male factor ART have been discussed with limited supporting data. Reassuring data for the safety of ICSI have been reported. The difference in ICSI experience and the preference for ICSI in many IVF centers around the world will keep the use of ICSI for non-male factor infertility popular.

In the future, the use of ICSI might be more restricted in some areas or countries. On the other side, the trend of using ICSI for non-male indications will keep going on. ICSI will still be the most common method of insemination in ART anyway, with the reassuring safety. And ICSI is no more an “add-on”, it is a part of modern ART practice.

Click here to watch video in separate window.

Have questions pertaining to this lecture? Leave your questions in the comment box below or send them to secretariat@aspire-reproduction.org. Questions collected will be addressed at the live forum session happening on Saturday, 17 October 2020 at 10am (GMT+8).

Lecture 2: Sperm Selection Techniques

Speaker: Dr. George Liperis (Sydney, Australia) [click to view speaker’s bio]

Sperm samples are known to have a complex heterogeneity. Swim up and density gradient centrifugation which are the current methodologies for sperm preparation are based on sperm motility and they are not efficient methods to select higher quality sperm. New methods have been developed that are based on sperm characteristics correlated to fertilization ability and quality of the spermatozoa to support embryonic development. Advanced sperm selection techniques are meant to improve the chance that structurally intact and mature sperm with high DNA integrity are selected for fertilization. The aim is therefore to identify sperm preparation and selection techniques that can improve sperm genetic integrity, fertilization capacity, embryo development, clinical outcomes and prove to be safe. In this lecture, the current methodologies of sperm preparation in a clinical setting are described along with the advanced sperm selection techniques. The effectiveness and safety of these techniques on ART outcomes is examined to identify the sperm selection techniques that can be incorporated into routine clinical practice.

Click here to watch video in separate window.

Have questions pertaining to this lecture? Leave your questions in the comment box below or send them to secretariat@aspire-reproduction.org. Questions collected will be addressed at the live forum session happening on Saturday, 17 October 2020 at 10am (GMT+8).

LIVE FORUM SESSION

Watch our forum session which was held on Saturday, 17 October 2020 at 10am (GMT+8).

Moderator: Associate Professor Louise Hull (Adelaide, Australia)

Panellists: Dr. Ho Manh Tuong (Ho Chi Minh, Vietnam), Dr George Liperis (Sydney, Australia)